000			03041nam a22003015i 4500
001			402621
003			ES-MaUEC
005			20240528105914.0
007			cr nn 008mamaa
008			230803s2023 sz | o |||| 0|eng d
020			_a9783031352133
024	7		_a10.1007/978-3-031-35213-3 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aR895-920 _b2023 EB
245	0	0	_aIntegrated Diagnostics and Theranostics of Thyroid Diseases _cedited by Luca Giovanella
250			_a1st ed. 2023
264		1	_aCham _bSpringer International Publishing _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aIntegrated Diagnostics: the future of Diagnostic Medicine? -- Artificial intelligence and machine learning in integrated diagnostic -- Thyroid dysfunctions: integrate to simplify -- Integrated thyroid imaging: ultrasound and scintigraphy -- Non-invasive imaging-biomarkers of thyroid nodules with indeterminate cytology -- Radioiodine Theranostics of benign thyroid diseases -- Radioiodine Theranostics of differentiated thyroid carcinoma -- Biomarkers and molecular imaging in postoperative DTC management -- Definition of radioactive iodine refractory thyroid cancer AND REDIFFERENTIATION STRATEGIES -- Integrated Diagnostics and Theranostics of Medullary Thyroid Carcinoma and Related Syndromes.
506	0		_aOpen Access
520			_aThis open access book provides basic concepts on Integrated Diagnostics and Theranostics with special emphasis on different human thyroid diseases. Thyroid diseases are increasingly detected (incidentally in many cases) but are clinically negligible in a significant proportion of patients. Accordingly, it is urgent to move from the simple disease detection to a reliable disease characterization in order to concentrate efforts on patients in need of tailored disease management. The current scenario of in vitro and in vivo diagnostics, is fastly moving toward the Integrated Diagnostics (i.e. convergence of imaging, pathology and laboratory tests with advanced information technology). Furthermore, the integration of different information will aid clinicians to properly select treatments and stratify patients' prognosis over time. Theranostics is a perfect paradigm of such integrated approach and radioiodine, indicated for benign and malignant thyroid disease management, was the first and is still the mostly used theranostic agent in medicine. Featuring basics concepts and clinical cases discussions the Atlas will be an invaluable tool for clinicians, laboratory specialists, imaging physicians and biomedical technologists involved in diagnosis and therapy of thyroid diseases.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-35213-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_Medicine_2023
999			_c402621 _d402621